Research Article

Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients

Table 1

Clinicopathological features of nondiabetes versus diabetes patients.

All patients
Patients without type 2 diabetes
Patients with
type 2 diabetes

Median age in years (range)70.9 (20.5, 101.2)69.6 (20.5–101.2)74.0 (26.5–93.3)
Sex
 Female (%)497 (44.5%)400 (45.7%)97 (40.3%)
 Male (%)619 (55.5%)475 (54.3%)144 (59.7%)
Site
 Right colon (%)533 (47.8%)407 (46.5%)126 (52.3%)
 Left colon (%)583 (52.2%)467 (53.4%)115 (47.7%)
T4 staging (%)176 (15.8%)131 (15.0%)45 (18.7%)
<12 lymph nodes examined275 (24.6%)208 (23.8%)67 (27.8%)
Poor differentiation (%)225 (20.2%)170 (19.4%)55 (22.8%)
Lymphovascular invasion266 (23.8%)211 (24.1%)55 (22.8%)
MSI status (%)
 MSI-stable441 (39.5%)351 (40.1%)90 (37.3%)
 MSI-high114 (10.2%)92 (10.5%)22 (9.1%)
 Not done536 (48.0%)413 (47.2%)123 (51.0%)
 Unknown25 (2.2%)19 (2.2%)6 (2.5%)
Emergency presentationa158 (14.2%)122 (13.9%)36 (14.9%)

aEmergency presentation includes bowel perforation or bowel obstruction.